ArticleInternational journal of cancer2021

A phase I study of the anaplastic lymphoma kinase inhibitor ceritinib in combination with gemcitabine-based chemotherapy in patients with advanced solid tumors.

Christos Fountzilas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.